Latest News about BIO
Recent news which mentions BIO
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 24, 2022
From Benzinga
From MarketWatch
From MarketWatch
A Look Into Healthcare Sector Value Stocks
November 01, 2021
From Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
Bio-Rad Laboratories, inc (BIO) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BIO
From Motley Fool
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
October 25, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
9 Moonshot Bets to Beat Hedge Funds at Their Own Game
October 22, 2021
From InvestorPlace
15 Under 40, 14 Over 90: A Look At The Youngest And Oldest Members Of The Forbes 400 List
October 09, 2021
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
September 27, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
This Unknown Biotech Has a Secret Weapon for Outsized Returns
August 21, 2021
From Motley Fool
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 16, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.